Text Size

Investigating the Effectiveness of Telepsychiatry for Treating Major Depression in a Chinese American Nursing Home

The recruitment status of this study is unknown because the information has not been verified recently.
Verified May 2008 by Massachusetts General Hospital.
Recruitment status was  Active, not recruiting
Sponsor:
Information provided by:
Massachusetts General Hospital
ClinicalTrials.gov Identifier:
NCT00505518
First received: July 19, 2007
Last updated: May 23, 2008
Last verified: May 2008
History of Changes
  Purpose

The current use of telepsychiatry, or psychiatric care using videoconferencing, is very limited. The present study investigates the use of this method with a depressed Chinese American population in a nursing home. It is believed that this population can benefit from telepsychiatric treatment when used in collaboration with the primary care they receive in the nursing home.


Condition Intervention
Major Depressive Disorder
 Drug: Psychotropic medication (at discretion of psychiatrist)
Behavioral: Collaborative psychiatric and primary medical care

Study Type: Interventional
Study Design: Endpoint Classification: Safety/Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Feasibility and Effectiveness of Telepsychiatry for Collaborative Management of Chinese Americans With Psychiatric Disorders in a Nursing Home

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by Massachusetts General Hospital:

Primary Outcome Measures:
  • Change in mean scores on Hamilton Rating Scale for Depression [ Time Frame: Duration of treatment ] [ Designated as safety issue: No ]
  • Change in mean scores on Social Functioning rating scale [ Time Frame: Duration of treatment ] [ Designated as safety issue: No ]
  • Change in mean scores on Clinical Global Impressions [ Time Frame: Duration of treatment ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Change in mean scores on patient satisfaction rating scale [ Time Frame: Duration of treatment ] [ Designated as safety issue: No ]
  • Scores on medication adherence scale (if on psychotropic medication) [ Time Frame: Duration of treatment ] [ Designated as safety issue: No ]

Estimated Enrollment: 12
Study Start Date: September 2006
Estimated Study Completion Date: December 2008
Primary Completion Date: April 2008 (Final data collection date for primary outcome measure)
Intervention Details:
    Drug: Psychotropic medication (at discretion of psychiatrist)
    Antidepressant medication, prescribed at discretion of psychiatrist
    Behavioral: Collaborative psychiatric and primary medical care
    Regular care visits from health workers
Detailed Description:

Individuals at the South Cove Manor nursing home will be referred to this study if they are experiencing depression. After meeting with the Principal Investigator (a psychiatrist), he will collaborate with the primary care physician and the nursing home staff to establish a treatment plan for the patient. Videoconferencing will be used by the P.I. for regular psychiatric visits with the patient as well as meetings with the nursing home staff to coordinate care for the patient. After collaboration between the two groups, treatment suggestions will be given to the patient's PCP to implement in the primary care setting. The patient's symptomology, mood, satisfaction of life and side effects of medication will be recorded regularly to measure the effects of treatment for analysis.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Clinical diagnosis of Major Depressive Disorder
  • Patient at South Cove Manor Nursing Home
  • Referred by nursing staff for psychiatric consultation

Exclusion Criteria:

  • Not competent to participate in psychiatric interviews
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00505518

Locations
United States, Massachusetts
Depression and Clinical Research Program at Massachusetts General Hospital
Boston, Massachusetts, United States, 02114
South Cove Manor
Boston, Massachusetts, United States, 02118
Sponsors and Collaborators
Massachusetts General Hospital
Investigators
Principal Investigator: Albert Yeung, S., M.D. Massachusetts General Hospital
  More Information

Additional Information:
Depression Clinical and Research Program  This link exits the ClinicalTrials.gov site

No publications provided

Responsible Party: Albert Yeung, Principal Investigator, Massachusetts General Hospital
ClinicalTrials.gov Identifier: NCT00505518     History of Changes
Other Study ID Numbers: 2006-P-001508
Study First Received: July 19, 2007
Last Updated: May 23, 2008
Health Authority: United States: Institutional Review Board

Keywords provided by Massachusetts General Hospital:
Major Depressive Disorder
Telepsychiatry
Chinese American
Nursing Home

Additional relevant MeSH terms:
Depressive Disorder
Depression
Depressive Disorder, Major
Mood Disorders
Mental Disorders
 Behavioral Symptoms
Psychotropic Drugs
Central Nervous System Agents
Therapeutic Uses
Pharmacologic Actions

ClinicalTrials.gov processed this record on May 16, 2013